Clinical Trial Update: Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates the combination of sorafenib and topotecan in patients with platinum-resistant recurrent ovarian cancer, reporting on efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Sorafenib (Sorafenib)
• Topotecan (topotecan)

Snippet

Sponsor: JSehouli | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED